UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                             -----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of The
                         Securities Exchange Act of 1934

        Date of report (Date of earliest event reported): April 28, 2006

                            HEALTHRENU MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

 Nevada                                000-21914                 84-1907744
--------------------------------      -------------          -------------------
(State or other jurisdiction of       (Commission               (IRS Employer
incorporation)                        File Number)           Identification No.)

        12777 Jones Road, Suite 481, Houston, TX                   77070
        ----------------------------------------                   -----
        (Address of Principal Executive Offices)                (Zip Code)

            Our telephone number, including area code: (281) 890-2561
                                                       --------------

                                     Not Applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of us under any of the following
provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))

<PAGE>

       Section 4 - Matters Related to Accountants and Financial Statements

Item 4.01.  Changes in Registrant's Certifying Accountant.

(a) On April 28, 2006, the independent accountants, Ham, Langston & Brezina LLP,
resigned as certifying accountant of HealthRenu Medical, Inc. (the "Company").

      The reports of Ham,  Langston and Brezina LLP on the  Company's  financial
statements  for the  fiscal  years  ended  September  30,  2005 and 2004 did not
contain an adverse opinion or disclaimer of opinion,  nor were they qualified or
modified as to uncertainty,  audit scope, or accounting  principle,  except that
the financial  statements for the fiscal years ended September 30, 2005 and 2004
contained  opinions  modified  to include an  explanatory  paragraph  related to
substantial  doubt  regarding  the  Company's  ability  to  continue  as a going
concern.

      In connection with its audits of the Company's financial  statements as of
September  30,  2005 and 2004 and for years then ended,  and  through  April 28,
2004,  there were no  disagreements  between the Company and Ham,  Langston  and
Brezina  LLP on any matter of  accounting  principles  or  practices,  financial
statement disclosure, or auditing scope or procedure, which disagreement, if not
resolved to the satisfaction of Ham,  Langston and Brezina LLP would have caused
Ham,  Langston and Brezina LLP to make  reference  to the subject  matter of the
disagreement  in connection  with its report on the financial  statements of the
Company for such years.

      During the fiscal  years  ended  September  30,  2005 and 2004 and through
April 28, 2006 there have been no  reportable  events (as defined in  Regulation
S-B Item 304 (a)(1)(iv)(B)).

(b)  Malone & Bailey PC has been  appointed,  by the Board of  Directors  of the
Company to serve as the Company's independent  accountants,  effective April 28,
2006.  Malone  & Bailey  PC was not  consulted  concerning  the  application  of
accounting principals to any specific completed or contemplated transaction,  or
the type of audit  opinion  that might be  rendered on the  Company's  financial
statements,  nor was a written  report  provided  to the Company nor oral advice
given by the new  accountant  that was an  important  factor  which the  Company
considered  in reaching a decision as to any  accounting,  auditing or financial
reporting issue.

                  Section 9 - Financial Statements and Exhibits

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

      16.1  Letter  from Ham,  Langston  and  Brezina  LLP  regarding  change of
certifying accountant.

                                       2
<PAGE>

                                   SIGNATURES

      Pursuant to the  requirements  of the Securities  Exchange Act of 1934, we
have duly  caused  this  report to be  signed on our  behalf by the  undersigned
hereunto duly authorized.

Date:  April 28, 2006

                                    HEALTHRENU MEDICAL, INC.
                                    (Registrant)

                                    By:  /s/  Robert W. Prokos
                                         ---------------------------------------
                                    Name:  Robert W. Prokos
                                    Title: President and Chief Executive Officer
{"company-data": {"conformed-name": "HEALTHRENU MEDICAL INC", "cik": "0000791118", "assigned-sic": "2844", "irs-number": "841022287", "state-of-incorporation": "CO", "fiscal-year-end": "0930"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-21914", "film-number": "06809547"}, "business-address": {"street1": "7255 E. QUINCY AVENUE", "street2": "SUITE 550", "city": "DENVER", "state": "CO", "zip": "80237", "phone": "303-437-9434"}, "mail-address": {"street1": "P O BOX 620", "city": "TAMPA", "state": "FL", "zip": "33601"}, "former-company": [{"former-conformed-name": "AGTSPORTS INC", "date-changed": "19930616"}, {"former-conformed-name": "ULTRATECH KNOWLEDGE SYSTEMS INC", "date-changed": "19920703"}, {"former-conformed-name": "AMERICAN MERGER CONTROL INC /CO/", "date-changed": "19900823"}]}
UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                             -----------------------

                                    FORM 8-K

                                 CURRENT REPORT

                     Pursuant to Section 13 or 15(d) of The
                         Securities Exchange Act of 1934

        Date of report (Date of earliest event reported): April 28, 2006

                            HEALTHRENU MEDICAL, INC.
             (Exact name of registrant as specified in its charter)

 Nevada                                000-21914                 84-1907744
--------------------------------      -------------          -------------------
(State or other jurisdiction of       (Commission               (IRS Employer
incorporation)                        File Number)           Identification No.)

        12777 Jones Road, Suite 481, Houston, TX                   77070
        ----------------------------------------                   -----
        (Address of Principal Executive Offices)                (Zip Code)

            Our telephone number, including area code: (281) 890-2561
                                                       --------------

                                     Not Applicable
          -------------------------------------------------------------
          (Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of us under any of the following
provisions (see General Instruction A.2. below):

|_| Written communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)

|_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)

|_| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange
Act (17 CFR 240.14d-2(b))

|_| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange
Act (17 CFR 240.13e-4(c))
Section 4 - Matters Related to Accountants and Financial Statements

Item 4.01.  Changes in Registrant's Certifying Accountant.

(a) On April 28, 2006, the independent accountants, Ham, Langston & Brezina LLP,
resigned as certifying accountant of HealthRenu Medical, Inc. (the "Company").

      The reports of Ham,  Langston and Brezina LLP on the  Company's  financial
statements  for the  fiscal  years  ended  September  30,  2005 and 2004 did not
contain an adverse opinion or disclaimer of opinion,  nor were they qualified or
modified as to uncertainty,  audit scope, or accounting  principle,  except that
the financial  statements for the fiscal years ended September 30, 2005 and 2004
contained  opinions  modified  to include an  explanatory  paragraph  related to
substantial  doubt  regarding  the  Company's  ability  to  continue  as a going
concern.

      In connection with its audits of the Company's financial  statements as of
September  30,  2005 and 2004 and for years then ended,  and  through  April 28,
2004,  there were no  disagreements  between the Company and Ham,  Langston  and
Brezina  LLP on any matter of  accounting  principles  or  practices,  financial
statement disclosure, or auditing scope or procedure, which disagreement, if not
resolved to the satisfaction of Ham,  Langston and Brezina LLP would have caused
Ham,  Langston and Brezina LLP to make  reference  to the subject  matter of the
disagreement  in connection  with its report on the financial  statements of the
Company for such years.

      During the fiscal  years  ended  September  30,  2005 and 2004 and through
April 28, 2006 there have been no  reportable  events (as defined in  Regulation
S-B Item 304 (a)(1)(iv)(B)).

(b)  Malone & Bailey PC has been  appointed,  by the Board of  Directors  of the
Company to serve as the Company's independent  accountants,  effective April 28,
2006.  Malone  & Bailey  PC was not  consulted  concerning  the  application  of
accounting principals to any specific completed or contemplated transaction,  or
the type of audit  opinion  that might be  rendered on the  Company's  financial
statements,  nor was a written  report  provided  to the Company nor oral advice
given by the new  accountant  that was an  important  factor  which the  Company
considered  in reaching a decision as to any  accounting,  auditing or financial
reporting issue.

                  Section 9 - Financial Statements and Exhibits

Item 9.01.  Financial Statements and Exhibits.

(d) Exhibits

      16.1  Letter  from Ham,  Langston  and  Brezina  LLP  regarding  change of
certifying accountant.

                                       2
SIGNATURES

      Pursuant to the  requirements  of the Securities  Exchange Act of 1934, we
have duly  caused  this  report to be  signed on our  behalf by the  undersigned
hereunto duly authorized.

Date:  April 28, 2006

                                    HEALTHRENU MEDICAL, INC.
                                    (Registrant)

                                    By:  /s/  Robert W. Prokos
                                         ---------------------------------------
                                    Name:  Robert W. Prokos
                                    Title: President and Chief Executive Officer